Application 203994
- Type
- ANDA
- Sponsor
- NORTHLAND
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FLUDEOXYGLUCOSE F18 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | 4-500mCi/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 24468-001 | Fludeoxyglucose F-18 | Fludeoxyglucose F-18 Injection | University of North Dakota | ANDA | Current |
| 72634-001 | Fludeoxyglucose F 18 | Fludeoxyglucose F 18 Injection | Northland Nuclear Medicine | ANDA | Current |
| 72634-001 | Fludeoxyglucose F 18 | Fludeoxyglucose F 18 Injection | Northland Nuclear Medicine | ANDA | Current |
| 72634-001 | Fludeoxyglucose F 18 | Fludeoxyglucose F 18 Injection | Northland Nuclear Medicine | ANDA | Current |